We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-7.04%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.97B
AUM Growth
-$164M
Cap. Flow
+$28.5M
Cap. Flow %
1.45%
Top 10 Hldgs %
74.92%
Holding
37
New
6
Increased
2
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$95.7M
2
HIVE
Aerohive Networks
HIVE
+$40M
3
ROKA
Sorrento Tech, Inc. Common Stock
ROKA
+$35M
4
CRCM
CARE.COM, INC.
CRCM
+$31.1M
5
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$20.3M

Top Sells

Rank Stock Value
1
FIO
FUSION-IO INC COM
FIO
+$79.5M
2
ITMN
INTERMUNE INC
ITMN
+$59.2M
3
EPZM
Epizyme, Inc
EPZM
+$40.3M
4
CVT
CVENT, INC.
CVT
+$26.4M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$6.74M

Sector Composition

Rank Sector Weight
1 Healthcare 48.22%
2 Communication Services 19.23%
3 Technology 18.17%
4 Consumer Discretionary 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences
ALIM
$12.2M 0.62%
150,376
– –
GYRE icon
27
Gyre Therapeutics
GYRE
$641M
$11.6M 0.59%
5,799
– –
ECOM
28
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$9.13M 0.46%
556,692
– –
AUPH icon
29
Aurinia Pharmaceuticals
AUPH
$1.91B
$8.15M 0.41%
+2,546,843
New +$9.05M
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$681M
$6.29M 0.32%
324,315
– –
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.24M 0.22%
173,896
– –
EXEL icon
32
Exelixis
EXEL
$13.3B
$3.38M 0.17%
2,207,000
– –
ARQL
33
DELISTED
Arqule Inc
ARQL
$2.82M 0.14%
2,520,316
– –
AGRX
34
DELISTED
Agile Therapeutics
AGRX
$218K 0.01%
15
+4
+36% +$61.8K
NURO
35
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$103K 0.01%
22
– –
ITMN
36
DELISTED
INTERMUNE INC
ITMN
– –
-1,341,000
Closed -$59.2M
FIO
37
DELISTED
FUSION-IO INC COM
FIO
– –
-7,038,379
Closed -$79.5M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return

NEA Management Company's Q3 2014 Portfolio in Review

As of Q3 2014, NEA Management Company held 37 positions worth $1.97B, down 7.7% from $2.13B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

NEA Management Company's Q3 2014 filing shows 6 new, 2 increased, 3 reduced and 2 closed positions. Its largest new stake was Ardelyx: 6,621,199 shares worth $94.1M. The largest sale was FUSION-IO INC COM, an estimated $79.5M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 46% a quarter earlier, followed by Communication Services and Technology.

  • NEA Management Company's largest Q3 2014 buy was Ardelyx: 6,621,199 shares worth $94.1M.
  • NEA Management Company added most to Orexigen Therapeutics, Inc. in Q3 2014, an estimated $9.52M increase.
  • NEA Management Company's biggest Q3 2014 reduction was Epizyme, Inc, cutting an estimated $40.3M.
  • NEA Management Company fully exited FUSION-IO INC COM in Q3 2014, selling an estimated $79.5M.
  • NEA Management Company's ten largest holdings make up 75% of its $1.97B portfolio in Q3 2014.
  • NEA Management Company opened 6 new positions and closed 2 in Q3 2014.
  • NEA Management Company's portfolio value fell 7.7% quarter-over-quarter to $1.97B.

Based on NEA Management Company's 13F filing for Q3 2014, filed 24 Oct 2014.